Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

NCT06434064 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Locally Advanced Unresectable Triple-Negative Breast Carcinoma
Metastatic Triple-Negative Breast Carcinoma

Interventions

PROCEDURE: Biopsy
PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
PROCEDURE: Echocardiography
PROCEDURE: Magnetic Resonance Imaging
DRUG: Pegylated Liposomal Doxorubicin Hydrochloride
DRUG: Tamoxifen

Sponsor

Roswell Park Cancer Institute